Poland· PL-100327554
Debridat
A trimebutine product containing trimebutinum, registered in Poland by Aga Kommerz spol. s r.o.. The same ATC class is registered in 6 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Trimebutine is registered in 6 of 19 countries.
Countries holding a registration under ATC A03AA05 (trimebutine), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 4 of them publish a price we can compare per daily dose
Trimebutine · ATC A03AA05
6 / 19 countries
- Canada
- Franceprice
- Japan
- Norwayprice
- Polandprice
- Switzerlandprice
Price per daily dose
What a daily dose of trimebutine costs, country by country.
Normalised to the WHO defined daily dose (0.6 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Trimebutine · price per daily dose (0.6 g)
USD · FX 28 Sept 2026
- FR France$0.54
The record
At a glance
URPL (Poland)- Active substance
- Trimebutinum
- Manufacturer
- Aga Kommerz spol. s r.o.
- Country
- Poland (PL)
- ATC code
- A03AA05
- ATC class
- Trimebutine
- Defined daily dose
- 0.6 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909991195441
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Trimebutine in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FranceDEBRICALM 100 mg, comprimé pelliculéPFIZER HOLDING FRANCE
- CanadaAPO-TRIMEBUTINEAPOTEX INC
- SpainPOLIBUTIN COMPRIMIDOS RECUBIERTOSDesma Laboratorio Farmaceutico S.L.
- NorwayDebridatPfizer
- SwitzerlandDebridat 100, FilmtablettenF. UHLMANN-EYRAUD AG
Authorised across Europe · EMA
The same active substance is authorised in 7 EEA countries. Names it is sold under:
- Bulgaria · Трибутин
- Spain · Polibutin
- France · Debricalm, Debridat
- Greece · Garapepsin, Ibutin
- Italy · Debridat, Digerent
- Portugal · Debridat
- Romania · Colperin, Debridat
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f21da4fc-8064-43a6-b30d-775992c9e24e GET /v1/drugs/f21da4fc-8064-43a6-b30d-775992c9e24e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Granulat do sporządzania zawiesiny doustnej",
"source": "urpl",
"strength": "7,87 mg/g",
"packaging": "05909991195441 ¦ Rp ¦ 104843\n1 butelka 250 ml",
"substance": "Trimebutinum 7.87 mg/g",
"common_name": "Trimebutinum",
"pl_product_id": "100327554",
"pozwolenie_nr": "316/14",
"auth_procedure": "IR",
"authorisation_validity": "2024-10-06"
}See everything about trimebutine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.